Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Shares Outstanding (Weighted Average) (2020 - 2025)

BioAtla (BCAB) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $58.7 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 21.84% year-over-year to $58.7 million; the TTM value through Sep 2025 reached $58.7 million, up 21.84%, while the annual FY2024 figure was $48.6 million, 1.67% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $58.7 million in Q3 2025 per BCAB's latest filing, up from $58.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $58.7 million in Q3 2025 and bottomed at $33.6 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $44.5 million, with a median of $47.7 million recorded in 2023.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 310.07% in 2021, down 58.06% in 2021.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $34.6 million in 2021, then grew by 12.63% to $38.9 million in 2022, then grew by 22.74% to $47.8 million in 2023, then increased by 1.67% to $48.6 million in 2024, then grew by 20.94% to $58.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $58.7 million in Q3 2025, $58.4 million in Q2 2025, and $58.2 million in Q1 2025.